Isotonix®全效維他命B群沖飲

維他命B12
維他命B12是一種由細菌產生的物質，存在於內臟、肝臟、牛肉、豬肉、蛋、全脂奶、芝士、全麥麵包及魚類中。此外，少量維他命B12亦可提取自麵豉及豆豉等經發酵的大豆製品。對素食者來說，服用維他命B12補充品以維持最佳健康是非常重要的。維他命B12參與能量的代謝過程。

葉酸
葉酸主要存在於水果及蔬菜中；深綠葉植物、橙、橙汁、豆類以及豌豆都是葉酸的豐富來源。而製造啤酒的酵母，除了是葉酸的來源之一，也提供額外的B類維他命。。葉酸與維他命B12互相合作，以助維持正常的紅血球細胞。此外，葉酸是輔酵素的其中一種成份，它參與核酸及核蛋白的形成。

維他命B2
維他命B2存在於肝臟、奶類產品、深綠色蔬菜及部份海產中。維他命B2的角色是輔酵素，與其他B類維他命合作。維他命B2促進健康的紅血球形成和支援神經系統健康。它能促進食物轉化成能量的過程。此外，維他命B2協助脂肪分解，並作為輔因子或協助者活化B6及葉酸。維他命B2為水溶性，，必須每日補充。

維他命B6
家禽、魚類、全穀物及香蕉是維他命B6的主要食物來源。維他命B6是蛋白質及氨基酸代謝作用所需的輔因子。維他命B6參與氨基酸的代謝作用。部份運動員適用的補充品亦含有維他命B6，因為它能協助將糖原轉化成葡萄糖作為肌肉組織的能量。攝取維他命B6顯示有助支援心血管健康。維他命B6應與其他維他命B群成員一同服用，以達到最佳效果。

鎂
富含鎂的食物包括未經打磨的穀物、果仁及綠色蔬菜。綠葉菜由於含大量葉綠素，因此是鎂的豐富來源。肉類、澱粉質、奶類及加工食品的鎂含量低。鎂是骨頭內礦物質部份的其中一種成份，是成年人正常鉀及鈣代謝作用的必要元素。鎂有助支援心血管、肌肉及神經健康。

鎂參與能量的釋放、協助身體應付壓力及調節新陳代謝。重要的是，人體需要鎂建立健康骨骼及牙齒。

鉀
鉀是儲存於肌肉中的電解質。富含鉀的食物包括香蕉、橙、哈蜜瓜、牛油果、未經煮熟的菠菜、椰菜及西芹。鉀是重要的常量礦物質，有助維持人體體液平衡，並在支援心血管健康和能量水平方面扮演重要角色。

維他命B1
硫胺素（維他命B1）在碳水化合物代謝及神經功能上擔當重要的角色，它是健康神經系統的必要物質，有助神經傳導物乙膽鹼及γ-氨基丁酸的製造。硫胺素亦參與能量代謝，並有助支援認知功能健康。硫胺素更有助維持神經及心血管系統的正常運作。

泛酸（維他命B5）
泛酸是將膽鹼轉成乙醯膽鹼的轉化劑，乙醯膽鹼協助支援認知健康。泛酸亦被用於能量釋放，以及脂肪、蛋白質及碳水化合物的代謝作用。

菸鹼酸（維他命B3）
菸鹼酸是水溶性維他命，是維持健康所需的物質。菸鹼酸有助消化系統運作，同時對食物轉成能量的過程非常重要。菸鹼酸亦稱為維他命B3，存在於奶類產品、家禽、魚類、瘦肉、果仁、蛋、豆類及添加營養的麵包及穀類食品中。

生物素
生物素的食物來源為蛋黃、花生、牛肝、奶類、穀類、杏仁及製造啤酒的酵母。生物素參與健康細胞的製造，以及脂肪和氨基酸的代謝作用。

甚麼是Isotonix全效維他命B群沖飲？
Isotonix全效維他命B群沖飲是等壓的營養組合，其中包含人體所需的必要B類維他命、鎂及鉀。這些營養互相合作，支援人體多方面的健康及生物過程。Isotonix全效維他命B群沖飲為人體提供維他命B12、B2（核黃素）、B6、葉酸、維他命B3（菸鹼酸）、B5、B1及生物素。葉酸與B12合作能分解、利用及製造新蛋白質。維他命B5則參與能量產生過程，並是製造神經傳導物乙膽鹼的必要成份，亦是由脂肪產生、輸送及釋放能量的必要元素。硫胺素、核黃素、菸鹼酸及生物素從多方面參與能量產生的過程。

如果一個人缺乏內因子並需要注射B12，使用Isotonix全效維他命B群沖飲對他／她有幫助嗎？
沒有。維他命B12需要一種內因子才能被適當吸收，此內因子是一種由胃壁細胞合成的蛋白質，才能與維他命B12結合。

為甚麼B類維他命對衰老過程那麼重要？
隨著年紀漸長，吸收B類維他命的能力自然下降，而認知功能受損的多種指標與B類維他命水平下降有關。長者普遍會因味覺下降而影響食慾，可能會利用很多減少胃酸的藥物，這會令他們容易缺乏維他命B12。維他命B12是極難消化和吸收的營養，同時也是參與多種人體功能的重要維他命之一；這些功能包括理想的神經系統功能、正常的脫氧核糖核酸（DNA）及核糖核酸（RNA）合成、能量產生及健康的血液。

飲用Isotonix B群沖飲有特定方法嗎？
Isotonix全效維他命B群沖飲可與其他Isotonix產品一併空肚飲用。

我既年輕又健康，為甚麼要飲用B群呢？
健康專家估計，每五個成年人中，就有一個缺乏足夠B類維他命。茹素、酗酒、服食大量處方或非處方藥物、消化功能不全、接受過胃部繞道手術或飲食不均衡的人士，尤其容易缺乏足夠維他命B。

Isotonix全效維他命B群沖飲有哪些警告或禁忌嗎？
如果你正在服用處方藥物或患有長期疾病，使用本產品前請諮詢醫護人員。

應該如何使用Isotonix全效維他命B群沖飲？
將一小瓶蓋（白色螺旋蓋）的粉末倒入透明瓶杯中，加水至瓶杯線上（60毫升），攪拌後飲用。本品為健康食品，每天飲用一次或按醫護人員指示飲用。空肚時飲用效果最佳。使用規定量的粉劑與水混合才會使本產品達到等滲狀態。

甚麼產品與Isotonix全效維他命B群沖飲使用效果最佳？
本產品可配合任何其他補充品使用，視乎你的營養需要而定。如希望提升能量，可使用Isotonix全效維他命B群沖飲與Isotonix巴西莓提升能量沖飲；如希望紓緩情緒，可使用Isotonix全效維他命B群沖飲與Isotonix左旋色胺酸沖飲。

飲用Isotonix全效維他命B群沖飲安全嗎？
Isotonix全效維他命B群沖飲安全及不含有害物質。本產品在美國製造，並於經美國食品及藥物管理局檢測的設備生產，符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

• Abbott L, Nadler J, Rude RK. Magnesium deficiency in alcoholism: possible contribution to osteoporosis and cardiovascular disease in alcoholics. Alcohol Clin Exp Res. 1994; 18:1076-1082.
• PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta—analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831.
• Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode.
• Alcohol Clin Exp Res. 1994; 18:1057-1068.
• Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079.
• Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
• Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307.
• Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426.
• Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441- 2444.
• Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160.
• Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362.
• Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996; 125:961-968.
• Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809.
• Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621.
• Christin Marandino, Vegetarian Times, August 1998 Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997; 126:497-504.
• Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age and older. N Engl J Med. 1997; 337:670-676.
• de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686.
• Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328.
• Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214.
• Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
• Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999; 889:107-119.
• Gong H, Amemiya T. Optic nerve changes in manganese-deficient rats. Exp Eye Res. 1999; 68:313-320.
• Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986- 990.
• Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL.
• Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
• Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000; 19(2 Suppl):83S-99S.
• Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats. Neuroscience Letters. 1999; 261:21-24.
• ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet.1995; 345:669-685.
• Jorde R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000;35:1154-1159.
• Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159.
• Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223.
• Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy.Lancet. 1995; 346:270-274.
• Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9.
• Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985; 313:1381-1384.
• Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205.
• Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
• Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27.
• Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9:61-69.
• Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
• Oginni LM, Sharp CA, Worsfold M, et al. Healing of rickets after calcium supplementation.Lancet. 1999; 353:296-297.
• Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999;159:2119-2120.
• Paolisso G, Sgamabato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM. Diabetes Care. 1989; 12:265-269.
• Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996; 16:257-263.
• Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73. Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993; 328:460-464.
• Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13:416-423.
• Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333:250-251.
• Roffe C, Fletcher S, Woods KL. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction. Br Heart J. 1994; 71:141-145.
• Saris N-EL, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects (review). Clinica Chimica Acta. 2000; 294:1-26.
• Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in
• Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:169-192.
• Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93.
• Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; 283:2822-2825.
• Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80.
• Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150.
• Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994; 124:1060-1064.
• Talbot JR, Guardo P, Seccia S, et al. Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers. Osteoporosis Int. 1999; 10:137-142.
• Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
• Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1998; 156:1143-1148.
• Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258.
• Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155.
• Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
• Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994; 343:816-819.
• Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.